Anyone else interpret this the same as me? From the quarterly cc regarding TKM-Ebola clinical hold:
"The FDA has placed a clinical hold on this program pending requested information on the mechanism of potential cytokine release and a modification to the protocol for the multiple ascending dose portion of the trial. We are focused on an expedient response and resolution to the clinical hold so that we can advance TKM-Ebola to the multiple ascending dose portion of our Phase I study. We expect to have this resolved by Q4 of this year."
Did MM mean that by the end of the 3rd qtr which I believe is one way to interpret this statement or did he mean during the 4th qtr of this year? If he meant by the start of Q4 that is less than 30 days away. Time will tell.
quarterly cc transcript:
Yeah, I finally figured out how to insert a link :^)